Feb 9, 2025 · The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders. Drug use disorders, particularly …

About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of …

Jan 1, 2015 · Alcohol, Drugs and Addictive Behaviours The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed …

Access to appropriate medications is shown to have substantial impacts on community health and the related economic indicators. Quality-assured, safe and effective medicines, vaccines and medical …

Sep 2, 2025 · Publications of the World Health Organization Home / Publications / Overview / Canada: A List of Essential Prescription Drugs and Related Products-Initial Recommendation 2025 (English)

Apr 13, 2011 · Substitution maintenance therapy with methadone or buprenorphine improves the health and social performance of opioid-dependent people and decreases the use of illicit drugs and the …

Jul 24, 2025 · The World Health Organization (WHO) and the United Nations Office on Drugs and Crime (UNODC) have jointly released a landmark report unveiling critical findings on the persistent and …

Nov 3, 1994 · Psychoactive substances are substances that, when taken in or administered into one's system, affect mental processes, e.g. cognition or affect. This term and its equivalent, psychotropic …

Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice …

Apr 1, 2025 · This report presents the first World Health Organization (WHO) analysis of antifungal agents in preclinical and clinical development. It covers systemic antifungal drugs in development …